cagA and vacA status and influence of Helicobacter pylori infection on serum oxidative DNA damage in Iranian patients with peptic ulcer disease

Irish Journal of Medical Science

Volumn 180, Issue 1, 2011, Pages 155-161

  Khodaii, Z ^a   Ghaderian, S M H ^a   Akbarzadeh Najar, R ^a   Nejati, H ^a   Tabatabaei Panah, A S ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

cagA; DNA damage; Helicobacter pylori; Peptic ulcer; vacA

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CAGA PROTEIN; DNA; IMMUNOGLOBULIN G; VACUOLATING TOXIN;

ADULT; ALLELE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA DAMAGE; DNA EXTRACTION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PEPTIC ULCER; POLYMERASE CHAIN REACTION; STOMACH MUCOSA; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DEOXYGUANOSINE; DNA DAMAGE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IRAN; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; VIRULENCE;

EID: 79954436659     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11845-010-0548-5     Document Type: Article

References (55)

1. Riegg SJ, Dunn BE, Blaser MJ (1995) Microbiology and pathogenesis of Helicobacter pylori. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL (eds) Infections of the gastrointestinal tract. Raven Press, New York, pp 535-550
2. Dunn BE, Cohen H, Blaser MJ (1997) Helicobacter pylori. Clin Microbiol Rev 10:720-741 (Pubitemid 27477732)
3. van Doorn LJ, Figueiredo C, Sanna R et al (1998) Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol 36:2597-2603 (Pubitemid 28380962)
4. Atherton JC (1998) H. pylori virulence factors. Br Med Bull 54:105-120 (Pubitemid 28105320)
5. Blaser MJ (1996) Role of vacA and the cagA locus of Helicobacter pylori in human disease. Aliment Pharmacol Ther 10 (Suppl 1):73-77 (Pubitemid 26122863)
6. Hussain SP, Hofseth LJ, Harris CC (2003) Radical causes of cancer. Nat Rev Cancer 3:276-285 (Pubitemid 37328863)
7. Everett SM, White KL, Schorah CJ et al (2000) In vivo DNA damage in gastric epithelial cells. Mutat Res 468:73-85 (Pubitemid 30345563)
8. Takane M, Sugano N, Iwasaki H, Iwano Y, Shimizu N, Ito K (2002) New biomarker evidence of oxidative DNA damage in whole saliva from clinically healthy and periodontally diseased individuals. J Periodontol 73:551-554 (Pubitemid 34546408)
9. Shinya T (1999) Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int 49:91-102
10. Shimoike T, Inoguchi T, Umeda F, Nawata H, Kawano K, Ochi H (2000) The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy. Metabolism 49:1030-1035 (Pubitemid 30641441)
11. Erzin Y, Altun S, Dobrucali A et al (2006) Analysis of serum antibody profile against H pylori VacA and CagA antigens in Turkish patients with duodenal ulcer. World J Gastroenterol 12:6869-6873 (Pubitemid 44811412)
12. Tan HJ, Rizal AM, Rosmadi MY, Goh KL (2005) Distribution of Helicobacter pylori cagA, cagE and vacA in different ethnic groups in Kuala Lumpur, Malaysia. J Gastroenterol Hepatol 20:589-594 (Pubitemid 40755272)
13. Misiewicz JJ (1995) Current insights in the pathogenesis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 7:701-703
14. Leunk RD (1991) Production of a cytotoxin by Helicobacter pylori. Rev Infect Dis 13 (Suppl 8): S686-S689
15. Goodman KJ, Correa P (1995) The transmission of Helicobacter pylori. A critical review of the evidence. Int J Epidemiol 24:875-887
16. Mendall MA (1997) Transmission of Helicobacter pylori. Semin Gastrointest Dis 8:113-123 (Pubitemid 27365852)
17. Davies GR, Simmonds NJ, Stevens TR, Grandison A, Blake DR, Rampton DS (1992) Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut 33:1467-1472
18. Khanzode SS, Khanzode SD, Dakhale GN (2003) Serum and plasma concentration of oxidant and antioxidants in patients of Helicobacter pylori gastritis and its correlation with gastric cancer. Cancer Lett 195:27-31 (Pubitemid 36588975)
19. Telford JL, Ghiara P, Dell'Orco M et al (1994) Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 179:1653-1658 (Pubitemid 24129582)
20. Ghiara P, Marchetti M, Blaser MJ et al (1995) Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun 63:4154-4160
21. Cover TL, Dooley CP, Blaser MJ (1990) Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 58:603-610 (Pubitemid 20072620)
22. Fox JG, Correa P, Taylor NS et al (1992) High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol 87:1554-1560
23. Peek RM Jr (2003) Intoxicated cells and stomach ulcers. Nat Genet 33:328-330 (Pubitemid 36278844)
24. Xiang Z, Censini S, Bayeli PF et al (1995) Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 63:94-98
25. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R (1999) Helicobacter pylori virulence and genetic geography. Science 284:1328-1333 (Pubitemid 29289653)
26. Mukhopadhyay AK, Kersulyte D, Jeong JY et al (2000) Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India. J Bacteriol 182:3219-3227 (Pubitemid 30326939)
27. Matteo MJ, Granados G, Perez CV, Olmos M, Sanchez C, Catalano M (2007) Helicobacter pylori cag pathogenicity island genotype diversity within the gastric niche of a single host. J Med Microbiol 56:664-669 (Pubitemid 46717492)
28. Bolek BK, Salih BA, Sander E (2007) Genotyping of Helicobacter pylori strains from gastric biopsies by multiplex polymerase chain reaction. How advantageous is it? Diagn Microbiol Infect Dis 58:67-70 (Pubitemid 46694273)
29. Jafarzadeh A, Rezayati MT, Nemati M (2007) Specific serum immunoglobulin G to H. pylori and CagA in healthy children and adults (south-east of Iran). World J Gastroenterol 13:3117-3121 (Pubitemid 47045472)
30. Dabiri H, Maleknejad P, Yamaoka Y et al (2009) Distribution of Helicobacter pylori cagA, cagE, oipA and vacA in different major ethnic groups in Tehran, Iran. J Gastroenterol Hepatol 24:1380-1386
31. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY (1999) Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 37:2274-2279 (Pubitemid 29277791)
32. Wong BC, Yin Y, Berg DE et al (2001) Distribution of distinct vacA, cagA and iceA alleles in Helicobacter pylori in Hong Kong. Helicobacter 6:317-324 (Pubitemid 34015013)
33. Datta S, Chattopadhyay S, Balakrish Nair G et al (2003) Virulence genes and neutral DNA markers of Helicobacter pylori isolates from different ethnic communities of West Bengal, India. J Clin Microbiol 41:3737-3743 (Pubitemid 36994710)
34. Chomvarin C, Namwat W, Chaicumpar K et al (2008) Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and babA2 genotypes in Thai dyspeptic patients. Int J Infect Dis 12:30-36 (Pubitemid 350299216)
35. Van Doorn LJ, Figueiredo C, Megraud F et al (1999) Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology 116:823-830 (Pubitemid 29153530)
36. Miehlke S, Kirsch C, Agha-Amiri K et al (2000) The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer 87:322-327 (Pubitemid 30451641)
37. Yamaoka Y, Kodama T, Graham DY, Kashima K (1998) Comparison of four serological tests to determine the CagA or VacA status of Helicobacter pylori strains. J Clin Microbiol 36:3433-3434 (Pubitemid 28476216)
38. Varocha M, Pisit T, Natnipa W, Piched S, Pinit K (1999) CagA and VacA: virulence factors of Helicobacter pylori in Thai patients with gastroduodenal diseases. Helicobacter 4:143-147
39. Shiesh SC, Sheu BS, Yang HB, Tsao HJ, Lin XZ (2000) Serologic response to lower-molecular-weight proteins of H. pylori is related to clinical outcome of H. pylori infection in Taiwan. Dig Dis Sci 45:781-788
40. Kuo CH, Wu DC, Lu CY et al (2003) Low molecular weight protein of Helicobacter pylori and its relation to gastroduodenal diseases. Hepatogastroenterology 50:897-901
41. Qiao W, Hu JL, Xiao B et al (2003) cagA and vacA genotype of Helicobacter pylori associated with gastric diseases in Xi'an area. World J Gastroenterol 9:1762-1766 (Pubitemid 37038126)
42. Cover TL, Tummuru MK, Cao P, Thompson SA, Blaser MJ (1994) Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 269:10566-10573 (Pubitemid 24198258)
43. Siavoshi F, Malekzadeh R, Daneshmand M, Ashktorab H (2005) Helicobacter pylori endemic and gastric disease. Dig Dis Sci 50:2075-2080 (Pubitemid 41504092)
44. Kamali-Sarvestani E, Bazargani A, Masoudian M, Lankarani K, Taghavi AR, Saberifiroozi M (2006) Association of H pylori cagA and vacA genotypes and IL-8 gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases. World J Gastroenterol 12:5205-5210 (Pubitemid 44355919)
45. Talebkhan Y, Mohammadi M, Mohagheghi MA et al (2007) cagA gene and protein status among Iranian Helicobacter pylori strains. Dig Dis Sci 53:925-932
46. Hussein NR, Mohammadi M, Talebkhan Y et al (2008) Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori-associated disease. J Clin Microbiol 46:1774-1779 (Pubitemid 351657228)
47. Saribasak H, Salih BA, Yamaoka Y, Sander E (2004) Analysis of Helicobacter pylori genotypes and correlation with clinical outcome in Turkey. J Clin Microbiol 42:1648-1651 (Pubitemid 38500811)
48. Chattopadhyay S, Datta S, Chowdhury A et al (2002) Virulence genes in Helicobacter pylori strains from West Bengal residents with overt H. pylori-associated disease and healthy volunteers. J Clin Microbiol 40:2622-2625 (Pubitemid 34747374)
49. Bagchi D, Bhattacharya G, Stohs SJ (1996) Production of reactive oxygen species by gastric cells in association with Helicobacter pylori. Free Radic Res 24:439-450 (Pubitemid 26188962)
50. Halliwell B, Aruoma OI (1991) DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett 281:9-19
51. Farinati F, Cardin R, Russo VM, Busatto G, Franco M, Rugge M (2003) Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: a potential pathway to cancer? Helicobacter 8:227-234 (Pubitemid 36712407)
52. Crabtree JE (1996) Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther 10:29-37 (Pubitemid 26122858)
53. Correa P (1980) The epidemiology and pathogenesis of chronic gastritis: three etiologic entities. Front Gastrointest Res 6:98-108
54. Correa P (1988) Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol 83:504-509
55. Weitzman SA, Gordon LI (1990) Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 76:655-663 (Pubitemid 20253278)